Economy
Bayer wins Roundup herbicide trial in the United States
The St. Louis ruling strengthens the company's strategy to reduce a legal liability that has exceeded $11 billion since the 2018 acquisition of Monsanto.
You have used your 3 free reads for today
The full text of this story becomes available after the daily renewal. Sports and entertainment stay open. The paid subscription is not open yet.
Your free reads renew on 11/15/2026 at 00:00 (Brasília time).
The essentials of this story
- What happened
- Bayer won a lawsuit regarding the safety of the herbicide Roundup.
- Who is affected
- The company Bayer and the plaintiffs in the lawsuit.
- What changes
- The verdict strengthens Bayer's position to resolve pending litigation and reduce its legal liability.
Create a free account to keep reading: 3 full stories a day.
The paid subscription is not on sale yet. Free sign-up already works. Planned monthly price: R$ 9.90 (in US dollars and euros, a direct conversion at the official rate on the day you subscribe).
Sources
- Bayer vence julgamento sobre acusação de que herbicida pode causar câncer — O Globo
- Bayer vence julgamento sobre acusações de câncer contra Roundup — Folha de S.Paulo — mercado
